ArticleCancers2020

Relapse-Free Survival and PD-L1 Expression in First High- and Low-Grade Relapsed Luminal, Basal and Double-Negative P53-Mutant Non-Muscular Invasive Bladder Cancer Depending on Previous Chemo- and Immunotherapy.

Ekaterina Blinova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.